333 related articles for article (PubMed ID: 12097330)
1. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles.
Grefhorst A; Elzinga BM; Voshol PJ; Plösch T; Kok T; Bloks VW; van der Sluijs FH; Havekes LM; Romijn JA; Verkade HJ; Kuipers F
J Biol Chem; 2002 Sep; 277(37):34182-90. PubMed ID: 12097330
[TBL] [Abstract][Full Text] [Related]
2. LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size.
Okazaki H; Goldstein JL; Brown MS; Liang G
J Biol Chem; 2010 Feb; 285(9):6801-10. PubMed ID: 20037162
[TBL] [Abstract][Full Text] [Related]
3. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.
Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F
J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210
[TBL] [Abstract][Full Text] [Related]
4. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
[TBL] [Abstract][Full Text] [Related]
5. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.
Liang G; Yang J; Horton JD; Hammer RE; Goldstein JL; Brown MS
J Biol Chem; 2002 Mar; 277(11):9520-8. PubMed ID: 11782483
[TBL] [Abstract][Full Text] [Related]
6. Phospholipid transfer protein is regulated by liver X receptors in vivo.
Cao G; Beyer TP; Yang XP; Schmidt RJ; Zhang Y; Bensch WR; Kauffman RF; Gao H; Ryan TP; Liang Y; Eacho PI; Jiang XC
J Biol Chem; 2002 Oct; 277(42):39561-5. PubMed ID: 12177004
[TBL] [Abstract][Full Text] [Related]
7. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
8. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
Cha JY; Repa JJ
J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.
Inaba T; Matsuda M; Shimamura M; Takei N; Terasaka N; Ando Y; Yasumo H; Koishi R; Makishima M; Shimomura I
J Biol Chem; 2003 Jun; 278(24):21344-51. PubMed ID: 12672813
[TBL] [Abstract][Full Text] [Related]
10. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice.
Peng D; Hiipakka RA; Dai Q; Guo J; Reardon CA; Getz GS; Liao S
J Pharmacol Exp Ther; 2008 Nov; 327(2):332-42. PubMed ID: 18723776
[TBL] [Abstract][Full Text] [Related]
11. Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice.
Grefhorst A; Parks EJ
J Lipid Res; 2009 Jul; 50(7):1374-83. PubMed ID: 19287042
[TBL] [Abstract][Full Text] [Related]
12. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.
Liang Y; Lin S; Beyer TP; Zhang Y; Wu X; Bales KR; DeMattos RB; May PC; Li SD; Jiang XC; Eacho PI; Cao G; Paul SM
J Neurochem; 2004 Feb; 88(3):623-34. PubMed ID: 14720212
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance.
Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW
J Biol Chem; 2004 Feb; 279(9):7636-42. PubMed ID: 14668345
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol feeding strongly reduces hepatic VLDL-triglyceride production in mice lacking the liver X receptor alpha.
van der Veen JN; Havinga R; Bloks VW; Groen AK; Kuipers F
J Lipid Res; 2007 Feb; 48(2):337-47. PubMed ID: 17088263
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.
Joseph SB; Laffitte BA; Patel PH; Watson MA; Matsukuma KE; Walczak R; Collins JL; Osborne TF; Tontonoz P
J Biol Chem; 2002 Mar; 277(13):11019-25. PubMed ID: 11790787
[TBL] [Abstract][Full Text] [Related]
17. Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.
Takanashi M; Kimura T; Li C; Tanaka M; Matsuhashi A; Yoshida H; Noda A; Xu P; Takase S; Okazaki S; Iizuka Y; Kumagai H; Ikeda Y; Gotoda T; Takahashi M; Yagyu H; Ishibashi S; Yamauchi T; Kadowaki T; Liang G; Okazaki H
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):373-386. PubMed ID: 30700132
[TBL] [Abstract][Full Text] [Related]
18. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression.
Ou X; Dai X; Long Z; Tang Y; Cao D; Hao X; Hu Y; Li X; Tang C
Sci China C Life Sci; 2008 May; 51(5):418-29. PubMed ID: 18785587
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
